AbbVie to Host First-Quarter 2025 Earnings Conference Call

AbbVie (NYSE: ABBV) has scheduled its first-quarter 2025 financial results announcement for Friday, April 25, 2025, before market opening.

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

AbbVie (NYSE: ABBV) has scheduled its first-quarter 2025 financial results announcement for Friday, April 25, 2025, before market opening. The company will host a live webcast earnings conference call at 8 a.m. Central time, which will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived version of the session will be made available later the same day.

Argus Session date unavailable

+2.06% session move Open Argus

Details

News Market Reaction – ABBV

The recorded move for ABBV in the trading session of this news was +2.06%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

03/31/2025 - 08:00 AM EDT

NORTH CHICAGO, Ill., March 31, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its first-quarter 2025 financial results on Friday, April 25, 2025, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology, neuroscience and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter) and YouTube.

Media:	Investors:
Gabby Tarbert	Liz Shea
(224) 244-0111	(847) 935-2211
gabrielle.tarbert@abbvie.com	liz.shea@abbvie.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-host-first-quarter-2025-earnings-conference-call-302414655.html

SOURCE AbbVie

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will AbbVie (ABBV) release Q1 2025 earnings?

AbbVie will release Q1 2025 earnings on Friday, April 25, 2025, before the market opens.

What time is AbbVie's (ABBV) Q1 2025 earnings call?

AbbVie's Q1 2025 earnings call is scheduled for 8 a.m. Central time on April 25, 2025.

How can investors access AbbVie's (ABBV) Q1 2025 earnings call?

Investors can access the live webcast through AbbVie's Investor Relations website at investors.abbvie.com.

Will AbbVie's (ABBV) Q1 2025 earnings call be available for replay?

Yes, an archived version of the earnings call will be available on AbbVie's website later the same day.

Keep reading

More on ABBV

All ABBV news

Trending in the feed

REVVF

Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario Open the live feed

From our desk

AbbVie Earnings: Sales Rise 10.3% as Skyrizi and Rinvoq More Than Replace Humira